Search Results - "Laban, Simon"

Erratum to: Analysis, identification and visualization of subgroups in genomics.

Authors: Völkel, Gunnar Laban, Simon Fürstberger, Axel et al.

Source: Briefings in Bioinformatics. Nov2021, Vol. 22 Issue 6, p1-1. 1p.

Co-Stimulatory and Immune Checkpoint Molecule Expression on Peripheral Immune Cells Differs Age Dependently Between Healthy Donors and Patients with Head and Neck Squamous Cell Carcinoma.

Authors: Puntigam, Lisa K. Grages, Ayla Vahl, Julius M. et al.

Source: Cancers. Oct2025, Vol. 17 Issue 19, p3215. 13p.

Analysis, identification and visualization of subgroups in genomics.

Authors: Völkel, Gunnar Laban, Simon Fürstberger, Axel et al.

Source: Briefings in Bioinformatics. May2021, Vol. 22 Issue 3, p1-12. 12p.

Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).

Authors: Bußmann, Lara Laban, Simon Wittekindt, Claus et al.

Source: BMC Cancer. 7/29/2020, Vol. 20 Issue 1, p1-13. 13p. 1 Diagram, 2 Charts.

Identification of B Cell Subpopulations with Pro- and Anti-Tumorigenic Properties in an Immunocompetent Mouse Model of Head and Neck Squamous Cell Carcinoma.

Authors: Sonntag, Michael Stanojevic, Sandra Laban, Simon et al.

Source: Cells (2073-4409). Jan2025, Vol. 14 Issue 1, p20. 22p.

Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern Germany.

Authors: Vahl, Julius M. Nagel, Gabriele Abou Kors, Tsima et al.

Source: Cancer Medicine. Dec2023, Vol. 12 Issue 23, p21426-21435. 10p.

Demographics and access to head and neck cancer care in rural areas compared to urban areas in Germany.

Authors: Vahl, Julius M. Nagel, Gabriele Grages, Ayla et al.

Source: Cancer Medicine. Sep2023, Vol. 12 Issue 18, p18826-18836. 11p.

Influence of Bruton's Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC).

Authors: Leichtle, Franziska Betzler, Annika C. Eizenberger, Carlotta et al.

Source: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13133. 15p.

BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression.

Authors: Betzler, Annika C. Strobel, Hannah Abou Kors, Tsima et al.

Source: Cancers. Jan2023, Vol. 15 Issue 1, p310. 19p.

Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck.

Authors: Doescher, Johannes Meyer, Moritz Arolt, Christoph et al.

Source: Cancers. Mar2022, Vol. 14 Issue 6, p1383. 12p.

Immuntherapie im Kontext anderer Therapiemodalitäten von Kopf-Hals-Tumoren – Highlights der ASCO- und ESMO-Jahrestagung 2022.

Alternate Title: Immunotherapy in the context of other head and neck cancer treatment modalities—highlights of the ASCO and ESMO annual meeting 2022.

Authors: von Witzleben, Adrian Hoffmann, Thomas K. Laban, Simon

Source: Best Practice Onkologie. Oct2023, Vol. 18 Issue 10, p462-467. 6p.

Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment Decisions.

Authors: von Witzleben, Adrian Müller-Richter, Urs Maurus, Katja et al.

Source: International Journal of Molecular Sciences. Dec2022, Vol. 23 Issue 24, p15835. 11p.

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice.

Authors: Brand, Matthias Laban, Simon Theodoraki, Marie-Nicole et al.

Source: International Journal of Molecular Sciences. Jan2021, Vol. 22 Issue 1, p247. 1p.

Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center.

Authors: Vahl, Julius M. Wigand, Marlene C. Denkinger, Michael et al.

Source: Cancers. 2/15/2021, Vol. 13 Issue 4, p832-832. 1p.

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy.

Authors: von Witzleben, Adrian Wang, Chuan Laban, Simon et al.

Source: Cells (2073-4409). Sep2020, Vol. 9 Issue 9, p2103. 1p.

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy.

Authors: Puntigam, Lisa K. Jeske, Sandra S. Götz, Marlies et al.

Source: International Journal of Molecular Sciences. Aug2020, Vol. 21 Issue 15, p5181. 1p.

Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.

Authors: Beccard, Inga J. Hofmann, Linda Schroeder, Jan C. et al.

Source: Cancers. Jul2020, Vol. 12 Issue 7, p1997. 1p.

Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.

Authors: Semrau, Sabine Gostian, Antoniu-Oreste Traxdorf, Maximilian et al.

Source: Cancers. Apr2021, Vol. 13 Issue 8, p1959. 1p.

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma.

Authors: Kötting, Charlotte Hofmann, Linda Lotfi, Ramin et al.

Source: Cancers. Mar2021, Vol. 13 Issue 6, p1335. 1p.

Peripheral Cytokine Levels Differ by HPV Status and Change Treatment-Dependently in Patients with Head and Neck Squamous Cell Carcinoma.

Authors: Mytilineos, Daphne Ezić, Jasmin von Witzleben, Adrian et al.

Source: International Journal of Molecular Sciences. Sep2020, Vol. 21 Issue 17, p5990-5990. 1p.